NEW YORK, Feb. 27, 2017 -- Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of DaVita Inc. securities (NYSE:DVA) from August 5, 2015 through October 21, 2016, inclusive (the “Class Period”). The lawsuit seeks to recover damages for DaVita investors under the federal securities laws.
To join the DaVita class action, go to http://rosenlegal.com/cases-1026.html or call Phillip Kim, Esq. or Kevin Chan, Esq. toll-free at 866-767-3653 or email [email protected] or [email protected] for information on the class action.
NO CLASS HAS YET BEEN CERTIFIED IN THE ABOVE ACTION. UNTIL A CLASS IS CERTIFIED, YOU ARE NOT REPRESENTED BY COUNSEL UNLESS YOU RETAIN ONE. YOU MAY ALSO REMAIN AN ABSENT CLASS MEMBER AND DO NOTHING AT THIS POINT. YOU MAY RETAIN COUNSEL OF YOUR CHOICE.
According to the lawsuit, throughout the Class Period Defendants made false and/or misleading statements and/or failed to disclose that: (1) DaVita and its senior executives purposefully steered patients into unnecessary insurance plans in order to maximize profits; (2) DaVita was using American Kidney Fund as a vehicle to facilitate these improper practices; (3) as such, DaVita’s revenues and profits were illegally obtained; (4) in turn, DaVita lacked effective internal controls over financial reporting; and (5) as a result, Defendants’ statements about DaVita’s business, operations, and prospects were false and misleading and/or lacked a reasonable basis. When the true details entered the market, the lawsuit claims that investors suffered damages.
A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than April 3, 2017. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation. If you wish to join the litigation, go to http://rosenlegal.com/cases-1026.html or to discuss your rights or interests regarding this class action, please contact Phillip Kim, Esq. or Kevin Chan, Esq. of Rosen Law Firm toll free at 866-767-3653 or via e-mail at [email protected] or [email protected].
Follow us for updates on LinkedIn: https://www.linkedin.com/company/the-rosen-law-firm or on Twitter: https://twitter.com/rosen_firm.
Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation.
Contact Information: Laurence Rosen, Esq. Phillip Kim, Esq. Kevin Chan, Esq. The Rosen Law Firm, P.A. 275 Madison Avenue, 34th Floor New York, NY 10016 Tel: (212) 686-1060 Toll Free: (866) 767-3653 Fax: (212) 202-3827 [email protected] [email protected] [email protected] www.rosenlegal.com


Bain Capital Nears Deal for Majority Stake in Volkswagen Marine Engine Unit Everllence
Anthropic AI Model Uncovers Vulnerabilities in Classified U.S. Government Systems During Security Test
SpaceX Stock Rebounds After Sharp Selloff, But Valuation Concerns Persist
Trump Orders DOJ Investigation Into Exxon, Chevron Over High Gas Prices
SpaceX, Charter Communications Explore Mobile Partnership to Expand Starlink Wireless Service
Tesla and NatPower Partner on $5 Billion Battery Storage Expansion in Europe
Fortescue Faces Class Action Over Sexual Harassment Claims at Australian Mining Sites
Johns Hopkins University Lays Off 110 Employees as Federal Research Funding Declines
OpenAI May Delay IPO to 2027 Amid $1 Trillion Valuation Goal
Pelosi Discloses Major Intel and Uber Call Option Purchases Worth Up to $6 Million
OpenAI IPO Delay Weighs on SoftBank Shares as AI Valuation Concerns Grow
Bayer Wins Major U.S. Supreme Court Roundup Lawsuit, Shares Surge
Micron Stock Surges on Strong AI Demand, Record Revenue, and Bullish Q4 Forecast
Doncasters Raises $919 Million in NYSE IPO as Aerospace Growth Accelerates
Apple Supplier Stocks Slide as Samsung, SK Hynix Lead Selloff After Apple Price Hikes
US Judge Seeks Explanation for DOJ’s Decision to Drop Gautam Adani Bribery Case
Samsung, SK Hynix to Unveil Record AI and Semiconductor Investment Plans Worth Over $646 Billion 



